| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |